Why We Age: Dysbiosis
For humans, the basic circuitry of our cells is governed by 23,000 genes, controlling everything from heartbeats to hormone pulses. However, there is an entirely different library of genes, roughly 3 million strong, all over and inside of our bodies. That vast ‘second genome’ belongs to the microbiome, and it includes trillions of resident bacteria, archaea, and viruses whose collective DNA (the metagenome) dwarfs the one coiled inside human nuclei. When this microbial operating system is well-tuned, it provides metabolites, vitamins, and immune cues that help the host run smoothly. With aging, however, this elegant symbiosis collapses into dysbiosis, a state marked by lower microbial diversity, leaky barriers, chronic inflammation, and metabolic noise.
In youth, the human gut is buzzing with a mix of helpful microbes working in harmony. With aging, however, that harmony fades, replaced with inflammation-stirring bugs that happily sip on your bile acids. This slide is so consistent that López-Otín and colleagues upgraded “dysbiosis” from bit player to full-fledged hallmark, grouping it with chronic inflammation at the “integrative” tier of aging biology.
The promotion wasn’t just semantic. Research has found that that warping the microbiome can accelerate frailty, while resetting it can roll back biological clocks in mice, humans and, intriguingly, progeroid models.
Fewer and different microbial species
Cross-sectional datasets of over 9,000 humans aged 18-101 reveal that gut communities grow increasingly idiosyncratic with age; in the healthiest elders, this uniqueness is driven by the depletion of domineering Bacteroides and a bloom of rarer microbes [1]. Centenarian surveys echo the pattern, spotlighting Akkermansia, Bifidobacterium and bile-acid-tinkering Odoribacter as potential pro-longevity bacterial species [2].
Mouse work has pushed the theme further: in a panel of genetically diverse strains, age-linked microbiome trajectories predicted which mice would be statistical Methuselahs and which would be more like mayflies [3].
Metabolic signatures
Chemical clues in blood and stool tell us how this shifting gut community affects the rest of the body. Indoles, molecules produced when bacteria break down the amino-acid tryptophan, show up more often in older adults who still have strong muscles and low C-reactive protein, a marker of inflammation. In contrast, another bacterial by-product called p-cresol-sulfate keeps turning up in frail seniors [4].
In particular, indole-3-propionic acid (IPA) has stepped into the spotlight. Lab work in mice has fund that IPA latches onto the aryl-hydrocarbon receptor (AhR), turns down the NF-κB inflammatory switch, tightens the gut barrier and, in some animal models, even lengthens healthy lifespan [5].
Connecting microbes to gerontology
The aging microbiome hijacks physiology along multiple converging routes. It stokes inflammaging: when scientists transplanted gut microbes from elderly mice into germ-free young mice, the recipients’ spleens lit up with hyper-active CD4⁺ T cells and a surge of inflammatory cytokines [6].
It also breaches the gut wall: age-skewed bacterial communities gnaw away at tight-junction proteins, letting lipopolysaccharide seep into the bloodstream, fueling metabolic syndrome and cognitive haze. On the other hand, a 2025 microbiome rejuvenation study that repeatedly dosed mice with youthful stool restored those junctions and calmed the inflammation [6, 7].
The aging microbiome scrambles the host’s chemical wiring. Populations that make short-chain fatty acids wither, starving colon cells of butyrate, while secondary bile acids drift toward cancer-related varieties; intriguingly, centenarians counter this trend by hoarding iso-allo-lithocholic acid, a bile acid with broad antimicrobial punch [8, 9]. Gut-educated T cells gradually move from tolerance-promoting regulators toward pro-inflammatory TH17 cells with age, a shift partly reversed when obese older adults were given Akkermansia muciniphila supplements for twelve weeks [10].
Demonstrating causation though transplants
Proving cause and effect is not easy when dealing with the microbiome, but there are three lines of research that have provided solid evidence. First, when stool from normal, wild-type animals is transplanted into Lmna-G609G or Ercc1-deficient fast-aging (progeroid) mice, both healthspan and lifespan markedly improved, and delivering just one next-generation probiotic, Akkermansia muciniphila, recapitulates much of that benefit [11].
Second, giving naturally aged mice a young animal’s microbiome normalises hippocampal metabolites, matures microglia, and restores maze-running memory; these findings were reproduced in a 2025 mouse trial that used “young-trained” donors to boost synaptic plasticity and cognition [12, 13].
Third, transplanting an aged microbial community into germ-free youngsters ignites an immediate surge of circulating cytokines and lipopolysaccharide and even dampens germinal-center reactions in Peyer’s patches, effectively fast-tracking inflammaging in otherwise youthful hosts [14, 15].
Together, these lines of research make a persuasive causal case: changing the microbiome’s age pushes the host’s biological age along with it. Collectively, these studies mean that dysbiosis satisfies the López-Otín criteria for inclusion as a hallmark of aging: age association, acceleration upon aggravation, and deceleration upon intervention.
Relationships to other hallmarks
The causality of aging is seldom one-directional. Dysbiosis amplifies chronic inflammation, while IL-6-soaked tissues reshape microbial niches. Mitochondrial dysfunction feeds into dysbiosis, as reactive oxygen species favor facultative anaerobes; conversely, short-chain fatty acids spruced up by a youthful microbiome support mitophagy. Even epigenetic drift and telomere attrition intersect with dysbiosis: microbial folate supply modulates DNA methylation, while butyrate is a histone deacetylase whisperer.
Future directions
Several open fronts will shape the next decade of “microbiome geroscience.” Vast multi-omics datasets, now topping 8,000 human stool and blood profiles, map at least three distinct “aging-microbiome archetypes.” Machine learning-based clocks trained on these gut read-outs already predict chronological age within 3 years and sometimes outperform DNA methylation panels, hinting at a future in which a single stool sample could outshine epigenetic arrays as an everyday aging gauge [16, 17].
Enthusiasm for long-term fecal microbiota transplantation (FMT) is tempered by potential safety issues, however. Recent work found that even after carefully screened fecal infusions, donor strains can shuttle genes around the recipient’s gut ecosystem, and virome-only transfers (FVT) are now being tested as a lower-risk alternative [18, 19].
The gut-brain axis remains a tantalizing therapeutic target. Ongoing trials are manipulating tryptophan-processing bacteria in Parkinson’s disease in order to see whether reshaping indole and kynurenine chemistry can slow motor decline. These trials are slated for completion in late 2025 [20, 21].
Precision gene editing has reached the microbiome itself: a 2024 Nature study used phage-packaged base editors to snip a pathogenic gene area from E. coli in situ, achieving 93% editing without carpet-bombing the gut flora, strongly suggesting that “CRISPR gardening” of resident microbes is feasible [22].
There are also environmental factors at play. Microbiome-friendly dietary practices, healthcare that uses antibiotics sparingly, and simple greenspace exposure that may introduce benign bacteria all vary widely between populations and areas.
Conclusion
Aging doesn’t just apply to human cells; trillions of microbes are involved as well. Dysbiosis is not a passive biomarker but an active switchboard operator, rerouting signals across immunity, metabolism and neuroendocrine lanes. However, the microbiome is far more malleable than nuclear DNA, as it is constantly being rebuilt by both food and environmental exposures. Some future gerotherapeutics may, therefore, look less like conventional therapeutic methods and more like ecological restoration projects that restore balance to bodily systems.
Literature
[1] Microbiome Ageing in Genetically Diverse Mice. Nat Microbiol 2025, 10, 1032–1033.
[2] Jiang, H.; Chen, C.; Gao, J. Extensive Summary of the Important Roles of Indole Propionic Acid, a Gut Microbial Metabolite in Host Health and Disease. Nutrients 2023, 15.
[3] Litichevskiy, L.; Considine, M.; Gill, J.; Shandar, V.; Cox, T.O.; Descamps, H.C.; Wright, K.M.; Amses, K.R.; Dohnalová, L.; Liou, M.J.; et al. Gut Metagenomes Reveal Interactions between Dietary Restriction, Ageing and the Microbiome in Genetically Diverse Mice. Nat Microbiol 2025, 10, 1240–1257.
[4] Sonowal, R.; Swimm, A.; Sahoo, A.; Luo, L.; Matsunaga, Y.; Wu, Z.; Bhingarde, J.A.; Ejzak, E.A.; Ranawade, A.; Qadota, H.; et al. Indoles from Commensal Bacteria Extend Healthspan. Proc Natl Acad Sci U S A 2017, 114, E7506–E7515.
[5] Wang, Y.; Zhang, X.; Qing, M.; Dang, W.; Bai, X.; Wang, Y.; Zhou, D.; Zhu, L.; Qing, D.; Zhang, J.; et al. Trends in Intestinal Aging: From Underlying Mechanisms to Therapeutic Strategies. Acta Pharm Sin B 2025.
[6] Fransen, F.; van Beek, A.A.; Borghuis, T.; El Aidy, S.; Hugenholtz, F.; van der Gaast – de Jongh, C.; Savelkoul, H.F.J.; de Jonge, M.I.; Boekschoten, M. V.; Smidt, H.; et al. Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice. Front Immunol 2017, 8..
[7] Sommer, F.; Bernardes, J.P.; Best, L.; Sommer, N.; Hamm, J.; Messner, B.; López-Agudelo, V.A.; Fazio, A.; Marinos, G.; Kadibalban, A.S.; et al. Life-Long Microbiome Rejuvenation Improves Intestinal Barrier Function and Inflammaging in Mice. Microbiome 2025, 13.
[8] Lu, Y.; Du, J.; Peng, S.; Wang, Y.; Xiao, Y. Therapeutic Potential of Isoallolithocholic Acid in Methicillin-Resistant Staphylococcus Aureus Peritoneal Infection. J Antibiot (Tokyo) 2025, 78, 166–180.
[9] Sato, Y.; Atarashi, K.; Plichta, D.R.; Arai, Y.; Sasajima, S.; Kearney, S.M.; Suda, W.; Takeshita, K.; Sasaki, T.; Okamoto, S.; et al. Novel Bile Acid Biosynthetic Pathways Are Enriched in the Microbiome of Centenarians. Nature 2021, 599, 458–464.
[10] Kang, C.H.; Jung, E.S.; Jung, S.J.; Han, Y.H.; Chae, S.W.; Jeong, D.Y.; Kim, B.C.; Lee, S.O.; Yoon, S.J. Pasteurized Akkermansia Muciniphila HB05 (HB05P) Improves Muscle Strength and Function: A 12-Week, Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients 2024, 16.
[11] Bárcena, C.; Valdés-Mas, R.; Mayoral, P.; Garabaya, C.; Durand, S.; Rodríguez, F.; Fernández-García, M.T.; Salazar, N.; Nogacka, A.M.; Garatachea, N.; et al. Healthspan and Lifespan Extension by Fecal Microbiota Transplantation into Progeroid Mice. Nat Med 2019, 25, 1234–1242.
[12] Cerna, C.; Vidal-Herrera, N.; Silva-Olivares, F.; Álvarez, D.; González-Arancibia, C.; Hidalgo, M.; Aguirre, P.; González-Urra, J.; Astudillo-Guerrero, C.; Jara, M.; et al. Fecal Microbiota Transplantation from Young-Trained Donors Improves Cognitive Function in Old Mice Through Modulation of the Gut-Brain Axis. Aging Dis 2025.
[13] Parker, A.; Romano, S.; Ansorge, R.; Aboelnour, A.; Le Gall, G.; Savva, G.M.; Pontifex, M.G.; Telatin, A.; Baker, D.; Jones, E.; et al. Fecal Microbiota Transfer between Young and Aged Mice Reverses Hallmarks of the Aging Gut, Eye, and Brain. Microbiome 2022, 10.
[14] Caetano-Silva, M.E.; Shrestha, A.; Duff, A.F.; Kontic, D.; Brewster, P.C.; Kasperek, M.C.; Lin, C.H.; Wainwright, D.A.; Hernandez-Saavedra, D.; Woods, J.A.; et al. Aging Amplifies a Gut Microbiota Immunogenic Signature Linked to Heightened Inflammation. Aging Cell 2024, 23.
[15] Stebegg, M.; Silva-Cayetano, A.; Innocentin, S.; Jenkins, T.P.; Cantacessi, C.; Gilbert, C.; Linterman, M.A. Heterochronic Faecal Transplantation Boosts Gut Germinal Centres in Aged Mice. Nat Commun 2019, 10.
[16] Shen, X.; Wang, C.; Zhou, X.; Zhou, W.; Hornburg, D.; Wu, S.; Snyder, M.P. Nonlinear Dynamics of Multi-Omics Profiles during Human Aging. Nat Aging 2024.
[17] Gopu, V.; Camacho, F.R.; Toma, R.; Torres, P.J.; Cai, Y.; Krishnan, S.; Rajagopal, S.; Tily, H.; Vuyisich, M.; Banavar, G. An Accurate Aging Clock Developed from Large-Scale Gut Microbiome and Human Gene Expression Data. iScience 2024, 27, 108538.
[18] Behling, A.H.; Wilson, B.C.; Ho, D.; Cutfield, W.S.; Vatanen, T.; O’Sullivan, J.M. Horizontal Gene Transfer after Faecal Microbiota Transplantation in Adolescents with Obesity. Microbiome 2024, 12.
[19] Mao, X.; Larsen, S.B.; Zachariassen, L.S.F.; Brunse, A.; Adamberg, S.; Mejia, J.L.C.; Larsen, F.; Adamberg, K.; Nielsen, D.S.; Hansen, A.K.; et al. Transfer of Modified Gut Viromes Improves Symptoms Associated with Metabolic Syndrome in Obese Male Mice. Nat Commun 2024, 15.
[21] Iwaniak, P.; Owe-Larsson, M.; Urbańska, E.M. Microbiota, Tryptophan and Aryl Hydrocarbon Receptors as the Target Triad in Parkinson’s Disease—A Narrative Review. Int J Mol Sci 2024, 25.
[22] Brödel, A.K.; Charpenay, L.H.; Galtier, M.; Fuche, F.J.; Terrasse, R.; Poquet, C.; Havránek, J.; Pignotti, S.; Krawczyk, A.; Arraou, M.; et al. In Situ Targeted Base Editing of Bacteria in the Mouse Gut. Nature 2024, 632, 877–884.
